# Firstsun Capital Bancorp: financial statements, quarterly

FSUN · Nasdaq · CIK 1709442 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fsun.md) · [Financials](/companies/fsun/financials.md) · [Filings](/companies/fsun/filings.md) · [Insiders](/companies/fsun/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fsun/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [33.4](/filings/0001709442-23-000030.md) | [37.9 d](/filings/0001709442-24-000013.md) | [39.2](/filings/0001709442-24-000025.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [6.8](/filings/0001709442-24-000074.md) | [6.4 d](/filings/0001709442-26-000017.md) | [3.0](/filings/0001709442-25-000047.md) | [6.5](/filings/0001709442-25-000077.md) | [6.1](/filings/0001709442-25-000082.md) | [3.8 d](/filings/0001709442-26-000017.md) | [6.1](/filings/0001709442-26-000029.md) | [6.6](/filings/0001709442-26-000046.md) | [5.1](/filings/0001709442-25-000082.md) | [7.2 d](/filings/0001709442-26-000017.md) | [4.8](/filings/0001709442-26-000029.md) | [(5.1)](/filings/0001709442-26-000046.md) |
| Net income | $m | [25.2](/filings/0001709442-24-000074.md) | [24.0 d](/filings/0001709442-26-000017.md) | [12.3](/filings/0001709442-25-000047.md) | [24.6](/filings/0001709442-25-000077.md) | [22.4](/filings/0001709442-25-000082.md) | [16.4 d](/filings/0001709442-26-000017.md) | [23.6](/filings/0001709442-26-000029.md) | [26.4](/filings/0001709442-26-000046.md) | [23.2](/filings/0001709442-25-000082.md) | [24.8 d](/filings/0001709442-26-000017.md) | [21.6](/filings/0001709442-26-000029.md) | [(22.9)](/filings/0001709442-26-000046.md) |
| Diluted EPS | $ per share | [1.00](/filings/0001709442-24-000074.md) | not reported | [0.45](/filings/0001709442-25-000047.md) | [0.88](/filings/0001709442-25-000077.md) | [0.79](/filings/0001709442-25-000082.md) | not reported | [0.83](/filings/0001709442-26-000029.md) | [0.93](/filings/0001709442-26-000046.md) | [0.82](/filings/0001709442-25-000082.md) | not reported | [0.76](/filings/0001709442-26-000029.md) | [(0.49)](/filings/0001709442-26-000046.md) |
| Basic EPS | $ per share | [1.01](/filings/0001709442-24-000074.md) | not reported | [0.46](/filings/0001709442-25-000047.md) | [0.90](/filings/0001709442-25-000077.md) | [0.81](/filings/0001709442-25-000082.md) | not reported | [0.85](/filings/0001709442-26-000029.md) | [0.95](/filings/0001709442-26-000046.md) | [0.83](/filings/0001709442-25-000082.md) | not reported | [0.77](/filings/0001709442-26-000029.md) | [(0.49)](/filings/0001709442-26-000046.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.4](/filings/0001709442-23-000030.md) | [0.5](/filings/0001709442-25-000008.md) | [0.4](/filings/0001709442-24-000025.md) | [0.5](/filings/0001709442-24-000065.md) | [0.6](/filings/0001709442-24-000074.md) | [0.6](/filings/0001709442-26-000017.md) | [0.6](/filings/0001709442-25-000047.md) | [0.8](/filings/0001709442-25-000077.md) | [0.7](/filings/0001709442-25-000082.md) | [0.7](/filings/0001709442-26-000046.md) | [0.4](/filings/0001709442-26-000029.md) | [1.0](/filings/0001709442-26-000046.md) |
| Total assets | $bn | [7.8](/filings/0001709442-24-000074.md) | [7.9](/filings/0001709442-26-000017.md) | [7.8](/filings/0001709442-25-000047.md) | [8.0](/filings/0001709442-25-000077.md) | [8.1](/filings/0001709442-25-000082.md) | [8.1](/filings/0001709442-26-000017.md) | [8.2](/filings/0001709442-26-000029.md) | [8.4](/filings/0001709442-26-000046.md) | [8.5](/filings/0001709442-25-000082.md) | [8.5](/filings/0001709442-26-000046.md) | [8.6](/filings/0001709442-26-000029.md) | [15.7](/filings/0001709442-26-000046.md) |
| Total liabilities | $bn | [6.9](/filings/0001709442-23-000030.md) | [7.0](/filings/0001709442-25-000008.md) | [6.8](/filings/0001709442-24-000025.md) | [7.0](/filings/0001709442-24-000065.md) | [7.1](/filings/0001709442-24-000074.md) | [7.1](/filings/0001709442-26-000017.md) | [7.1](/filings/0001709442-25-000047.md) | [7.3](/filings/0001709442-25-000077.md) | [7.4](/filings/0001709442-25-000082.md) | [7.3](/filings/0001709442-26-000046.md) | [7.4](/filings/0001709442-26-000029.md) | [13.9](/filings/0001709442-26-000046.md) |
| Shareholders' equity | $bn | [0.8](/filings/0001709442-24-000074.md) | [0.9](/filings/0001709442-26-000017.md) | [1.0](/filings/0001709442-25-000077.md) | [1.0](/filings/0001709442-25-000082.md) | [1.0](/filings/0001709442-25-000082.md) | [1.0](/filings/0001709442-26-000046.md) | [1.1](/filings/0001709442-26-000046.md) | [1.1](/filings/0001709442-26-000046.md) | [1.1](/filings/0001709442-25-000082.md) | [1.2](/filings/0001709442-26-000046.md) | [1.2](/filings/0001709442-26-000046.md) | [1.8](/filings/0001709442-26-000046.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [18.7 d](/filings/0001709442-24-000074.md) | [41.0 d](/filings/0001709442-26-000017.md) | [27.1](/filings/0001709442-25-000047.md) | [20.9 d](/filings/0001709442-25-000077.md) | [48.1 d](/filings/0001709442-25-000082.md) | [5.0 d](/filings/0001709442-26-000017.md) | [26.4](/filings/0001709442-26-000029.md) | [15.0 d](/filings/0001709442-26-000046.md) | [49.4 d](/filings/0001709442-25-000082.md) | [20.8 d](/filings/0001709442-26-000017.md) | [(12.4)](/filings/0001709442-26-000029.md) | [1,104 d](/filings/0001709442-26-000046.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001709442-24-000074.md) | [2.9 d](/filings/0001709442-26-000017.md) | [1.0](/filings/0001709442-25-000047.md) | [1.1 d](/filings/0001709442-25-000077.md) | [1.1 d](/filings/0001709442-25-000082.md) | [2.3 d](/filings/0001709442-26-000017.md) | [2.0](/filings/0001709442-26-000029.md) | [2.0 d](/filings/0001709442-26-000046.md) | [1.8 d](/filings/0001709442-25-000082.md) | [1.8 d](/filings/0001709442-26-000017.md) | [1.8](/filings/0001709442-26-000029.md) | [(0.1) d](/filings/0001709442-26-000046.md) |
| Dividends paid | $m | not reported | not reported | [0.0](/filings/0001709442-25-000047.md) | not reported | not reported | not reported | [0.0](/filings/0001709442-26-000029.md) | [0.0](/filings/0001709442-26-000046.md) | not reported | not reported | [0.0](/filings/0001709442-26-000029.md) | [25.0](/filings/0001709442-26-000046.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [25.5](/filings/0001709442-23-000030.md) | [25.5](/filings/0001709442-24-000025.md) | [25.2](/filings/0001709442-24-000065.md) | [25.4](/filings/0001709442-24-000074.md) | [27.6](/filings/0001709442-25-000047.md) | [28.0](/filings/0001709442-25-000077.md) | [28.2](/filings/0001709442-25-000082.md) | [28.3](/filings/0001709442-26-000029.md) | [28.2](/filings/0001709442-26-000046.md) | [28.3](/filings/0001709442-25-000082.md) | [28.3](/filings/0001709442-26-000029.md) | [46.7](/filings/0001709442-26-000046.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 27,923,333 at 2026-03-05, from the cover of the [10-K filed 2026-03-06](/filings/0001709442-26-000017.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.